Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03343106 · ClinicalTrials.gov registry record · NA
Combining Acceptance and Commitment Therapy With Exposure and Response Prevention to Enhance Treatment Engagement
A NA study, sponsored by Utah State University.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT03343106 is a NA study that has completed, run by Utah State University. The registered enrollment target is 58 participants.
The verdict
NCT03343106, a NA study, has completed, sponsored by Utah State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
The aim of the study was to evaluate whether integrating Acceptance and Commitment Therapy (ACT) with Exposure and Response Prevention (ERP) increases the acceptability, tolerability, and adherence with ERP techniques relative to ERP without ACT. Fifty-eight adults with a DSM-IV diagnosis of Obsessive-Compulsive Disorder (OCD) received 16 twice-weekly sessions (2 hours per session) of either ERP with the inclusion of ACT techniques (ERP+ACT; n = 30) or ERP alone (n = 28). Assessments using interviews, self-report questionnaires, and behavioral observations were conducted at pre- and post-test, and at 6 month follow-up. Specific hypotheses were: 1) Patients receiving ERP+ACT will report greater treatment acceptability, and show higher quantity and quality of completed self-directed ERP assignments, relative to patients receiving standard ERP; 2) Both ERP and ERP+ACT will lead to clinically significant reductions in OCD symptoms from pre- to post-test and from pre-test to follow-up.
Interventions
- BEHAVIORAL ACT plus ERP
- BEHAVIORAL ERP alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2011-07-12 |
| Est. Completion | 2017-01-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03343106
The ClinicalTrials.gov registry entry for NCT03343106 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Utah State University, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ACT plus ERP is the first listed.
NCT03343106 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03343106 about?
NCT03343106 is a clinical study titled "Combining Acceptance and Commitment Therapy With Exposure and Response Prevention to Enhance Treatment Engagement". The aim of the study was to evaluate whether integrating Acceptance and Commitment Therapy (ACT) with Exposure and Response Prevention (ERP) increases the acceptability, tolerability, and adherence with ERP techniques relative to ERP without ACT. Fifty-eight adults with a DSM-IV diagnosis of Obsessi...
What is the current status of trial NCT03343106?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2011-07-12. Estimated completion is 2017-01-09.
What interventions are being tested in trial NCT03343106?
The interventions under investigation include: ACT plus ERP (BEHAVIORAL), ERP alone (BEHAVIORAL).
Who is sponsoring clinical trial NCT03343106?
This trial is sponsored by Utah State University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.